313 related articles for article (PubMed ID: 18589167)
1. Exendin-4 does not promote Beta-cell proliferation or survival during the early post-islet transplant period in mice.
Crutchlow MF; Yu M; Bae YS; Deng S; Stoffers DA
Transplant Proc; 2008 Jun; 40(5):1650-7. PubMed ID: 18589167
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets.
Juang JH; Kuo CH; Wu CH; Juang C
Cell Transplant; 2008; 17(6):641-7. PubMed ID: 18819252
[TBL] [Abstract][Full Text] [Related]
3. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
[TBL] [Abstract][Full Text] [Related]
4. XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model.
Plesner A; Soukhatcheva G; Korneluk RG; Verchere CB
Islets; 2010; 2(1):18-23. PubMed ID: 21099289
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome.
Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T
Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218
[TBL] [Abstract][Full Text] [Related]
6. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass.
Kaufman DB; Gores PF; Field MJ; Farney AC; Gruber SA; Stephanian E; Sutherland DE
Diabetes; 1994 Jun; 43(6):778-83. PubMed ID: 8194663
[TBL] [Abstract][Full Text] [Related]
7. New mouse model to study islet transplantation in insulin-dependent diabetes mellitus.
Mathews CE; Langley SH; Leiter EH
Transplantation; 2002 Apr; 73(8):1333-6. PubMed ID: 11981430
[TBL] [Abstract][Full Text] [Related]
8. Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice.
Ohmura Y; Tanemura M; Kawaguchi N; Machida T; Tanida T; Deguchi T; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Matsuura N; Ito T; Nagano H; Doki Y; Mori M
Transplantation; 2010 Dec; 90(12):1366-73. PubMed ID: 21076379
[TBL] [Abstract][Full Text] [Related]
9. In vivo treatment with glucagon-like peptide 1 promotes the graft function of fetal islet-like cell clusters in transplanted mice.
Suen PM; Li K; Chan JC; Leung PS
Int J Biochem Cell Biol; 2006; 38(5-6):951-60. PubMed ID: 16172015
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the Foreign Body Reaction in Marginal Mass Device-less Subcutaneous Islet Transplantation in Mice.
Pepper AR; Pawlick R; Bruni A; Gala-Lopez B; Wink J; Rafiei Y; Bral M; Abualhassan N; Shapiro AM
Transplantation; 2016 Jul; 100(7):1474-9. PubMed ID: 27136258
[TBL] [Abstract][Full Text] [Related]
11. Neural crest stem cells increase beta cell proliferation and improve islet function in co-transplanted murine pancreatic islets.
Olerud J; Kanaykina N; Vasylovska S; King D; Sandberg M; Jansson L; Kozlova EN
Diabetologia; 2009 Dec; 52(12):2594-601. PubMed ID: 19823803
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes.
Sharma A; Sörenby A; Wernerson A; Efendic S; Kumagai-Braesch M; Tibell A
Diabetologia; 2006 Jun; 49(6):1247-53. PubMed ID: 16609877
[TBL] [Abstract][Full Text] [Related]
13. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
14. Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment.
King A; Lock J; Xu G; Bonner-Weir S; Weir GC
Diabetologia; 2005 Oct; 48(10):2074-9. PubMed ID: 16132945
[TBL] [Abstract][Full Text] [Related]
15. Transient beneficial effects of exendin-4 treatment on the function of microencapsulated mouse pancreatic islets.
Bohman S; Waern I; Andersson A; King A
Cell Transplant; 2007; 16(1):15-22. PubMed ID: 17436851
[TBL] [Abstract][Full Text] [Related]
16. A preconditioning regimen with a PKCɛ activator improves islet graft function in a mouse transplant model.
Hamilton D; Rugg C; Davis N; Kvezereli M; Tafti BA; Busque S; Fontaine M
Cell Transplant; 2014; 23(7):913-9. PubMed ID: 23562311
[TBL] [Abstract][Full Text] [Related]
17. Nerve Growth Factor Improves Survival and Function of Transplanted Islets Via TrkA-mediated β Cell Proliferation and Revascularization.
Hata T; Sakata N; Yoshimatsu G; Tsuchiya H; Fukase M; Ishida M; Aoki T; Katayose Y; Egawa S; Unno M
Transplantation; 2015 Jun; 99(6):1132-43. PubMed ID: 25806408
[TBL] [Abstract][Full Text] [Related]
18. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.
Emamaullee JA; Stanton L; Schur C; Shapiro AM
Diabetes; 2007 May; 56(5):1289-98. PubMed ID: 17303806
[TBL] [Abstract][Full Text] [Related]
19. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
[TBL] [Abstract][Full Text] [Related]
20. Monocyte-Derived Dendritic Cells Impair Early Graft Function Following Allogeneic Islet Transplantation.
Chow KV; Carrington EM; Zhan Y; Lew AM; Sutherland RM
Cell Transplant; 2017 Feb; 26(2):319-326. PubMed ID: 27743446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
